114 related articles for article (PubMed ID: 7928505)
1. A new method for delivering radioactive cytotoxic agents in solid cancers.
Order SE; Siegel JA; Lustig RA; Principato R; Zeiger LS; Johnson E; Zhang H; Lang P; Pilchik NB; Metz J
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):715-20. PubMed ID: 7928505
[TBL] [Abstract][Full Text] [Related]
2. Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P.
Nguyen H; Ghanem G; Morandini R; Verbist A; Larsimont D; Fallais C; Frühling J; Van Houtte P
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):481-7. PubMed ID: 9308954
[TBL] [Abstract][Full Text] [Related]
3. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
Lee I; Lee YH
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P.
Lee I; Wallner PE
Cancer; 1997 Dec; 80(12 Suppl):2611-7. PubMed ID: 9406715
[TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 and iodine-131 radioimmunoglobulin therapy of an experimental human hepatoma.
Klein JL; Nguyen TH; Laroque P; Kopher KA; Williams JR; Wessels BW; Dillehay LE; Frincke J; Order SE; Leichner PK
Cancer Res; 1989 Nov; 49(22):6383-9. PubMed ID: 2553255
[TBL] [Abstract][Full Text] [Related]
6. Internal radiotherapy using 32P colloid or microsphere for refractory solid tumors.
Gao W; Liu L; Teng GJ; Feng GS; Tong GS; Gao NR
Ann Nucl Med; 2008 Oct; 22(8):653-60. PubMed ID: 18982467
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience of infusional brachytherapy using colloidal 32P.
Order SE; Siegel JA; Principato R; Zeiger LS; Johnson E; Lang P; Lustig R; Kroprowski C; Wallner PE
Ann Acad Med Singap; 1996 May; 25(3):347-51. PubMed ID: 8876899
[TBL] [Abstract][Full Text] [Related]
9. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor targeting by an intratumoral injection of colloidal chromic 32P in two human tumors (AsPC-1 pancreas and Ls174T colon) in nude mice.
Lee I
J Surg Oncol; 1999 Mar; 70(3):161-6. PubMed ID: 10102345
[TBL] [Abstract][Full Text] [Related]
11. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study.
Order SE; Stillwagon GB; Klein JL; Leichner PK; Siegelman SS; Fishman EK; Ettinger DS; Haulk T; Kopher K; Finney K
J Clin Oncol; 1985 Dec; 3(12):1573-82. PubMed ID: 2415692
[TBL] [Abstract][Full Text] [Related]
12. The theoretical implications and experimental and clinical results of radiolabeled antiferritin.
Order SE
Acta Oncol; 1990; 29(6):689-94. PubMed ID: 2223137
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
Weil-Hillman G; Runge W; Jansen FK; Vallera DA
Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of human hepatocellular carcinoma xenografts with 131I-labelled antiferritin antibody.
Saiful Alam AF
Br J Cancer; 1991 Apr; 63(4):503-7. PubMed ID: 2021533
[TBL] [Abstract][Full Text] [Related]
15. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
[TBL] [Abstract][Full Text] [Related]
16. Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody.
Rostock RA; Klein JL; Leichner P; Kopher KA; Order SE
Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1345-50. PubMed ID: 6885547
[TBL] [Abstract][Full Text] [Related]
17. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study.
Order SE; Siegel JA; Principato R; Zeiger LE; Johnson E; Lang P; Lustig R; Wallner PE
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1117-26. PubMed ID: 8985034
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
[TBL] [Abstract][Full Text] [Related]
20. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
